The Ten-Year Risk Prediction for Cardiovascular Disease for Malaysian Adults Using the Laboratory-Based and Office-Based (Globorisk) Prediction Model

Background and Objectives: Globorisk is a well-validated risk prediction model that predicts cardiovascular disease (CVD) in the national population of all countries. We aim to apply the Globorisk calculator and provide the overall, sex-specific, ethnic-specific, region-specific, and state-specific...

Full description

Saved in:
Bibliographic Details
Published in:Medicina (Kaunas, Lithuania) Lithuania), 2022-05, Vol.58 (5), p.656
Main Authors: Che Nawi, Che Muhammad Nur Hidayat, Omar, Mohd Azahadi, Keegan, Thomas, Yu, Yong-Poh, Musa, Kamarul Imran
Format: Article
Language:English
Subjects:
Adult
Age
Asian People
Blood pressure
Blood tests
Body mass index
Cardiovascular disease
Cardiovascular Diseases - epidemiology
Cholesterol
Datasets
Diabetes
Fatalities
Female
Globorisk
Glucose
Heart attacks
Humans
Laboratories
Malaysia
Male
Population
Public health
Risk Factors
Stroke
ten-year risk prediction
Womens health
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background and Objectives: Globorisk is a well-validated risk prediction model that predicts cardiovascular disease (CVD) in the national population of all countries. We aim to apply the Globorisk calculator and provide the overall, sex-specific, ethnic-specific, region-specific, and state-specific 10-year risk for CVD among Malaysian adults. Materials and Methods: Using Malaysia’s risk factor levels and CVD event rates, we calculated the laboratory-based and office-based risk scores to predict the 10-year risk for fatal CVD and fatal plus non-fatal CVD for the Malaysian adult population. We analysed data from 8253 participants from the 2015 nationwide Malaysian National Health and Morbidity Survey (NHMS 2015). The average risk for the 10-year fatal and fatal plus non-fatal CVD was calculated, and participants were further grouped into four categories: low risk (
ISSN:1648-9144
1010-660X
1648-9144
DOI:10.3390/medicina58050656